The current financial score of Beauty Health Co is 6.60. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 72.11M, representing a year-over-year decrease of 7.77%, while its net profit experienced a year-over-year decrease of 113.54%.
The current valuation score of Beauty Health Co is 8.33. Its current P/E ratio is -14.57, which is -404.67% below the recent high of 44.38 and -1413.41% above the recent low of -220.43.
The current earnings forecast score of Beauty Health Co is 5.78. The average price target is 0.99, with a high of 1.50 and a low of 0.70.
The current price momentum score of Beauty Health Co is 3.59. Currently, the stock price is trading between the resistance level at 0.74 and the support level at 0.63, making it suitable for range-bound swing trading.
The current institutional shareholding score of Beauty Health Co is 10.00. The latest institutional shareholding proportion is 93.44%, representing a quarter-over-quarter increase of 5.93%. The largest institutional shareholder is James Simons, holding a total of 364.69K shares, representing 0.00% of shares outstanding, with 163.64% increase in holdings.
The current risk assessment score of Beauty Health Co is 2.03. The company's beta value is 1.10. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.